PURPOSE: To quantitatively analyze and compare the fundoscopic features between fellow eyes of retinal angiomatous proliferation and typical exudative age-related macular degeneration and to identify possible predictors of neovascularization. METHODS: Retrospective case-control study. Seventy-nine fellow eyes of unilateral retinal angiomatous proliferation (n = 40) and typical exudative age-related macular degeneration (n = 39) were included. Fundoscopic features of the fellow eyes were assessed using digital color fundus photographs taken at the time of diagnosis of neovascularization in the first affected eye. Grading was performed by two independent graders using RetmarkerAMD, a computer-assisted grading software based on the Internat...
Retinal angiomatous proliferation (RAP) is a distinct form of choroidal neovascularization which may...
Item does not contain fulltextPURPOSE: To identify genetic and environmental risk factors in patient...
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for...
Purpose: To identify signs occurring more frequently in retinal angiomatous proliferation (RAP) lesi...
Retinal angiomatous proliferations (RAP) are one rare exudative maculopathy, occurring only in 10% o...
BACKGROUND: The aim of this study was to identify the clinical and angiographic features of retinal ...
Objectives: To present the multimodal imaging characteristics of precursor retinal angiomatous proli...
Objectives: To present the multimodal imaging characteristics of precursor retinal angiomatous proli...
Purpose: To describe the photoreceptor–retinal pigment epithelium (RPE) interface changes and to ana...
Abstract PURPOSE: To study the advent of exudative age-related macular degeneration in uninvolved fe...
Abstract PURPOSE: To study the advent of exudative age-related macular degeneration in uninvolved fe...
WOS: 000432603700004PubMed ID: 29755818Objectives: To present the multimodal imaging characteristics...
Objective: To report the management of retinal angiomatous proliferation (RAP), a recently described...
PURPOSE: To identify genetic and environmental risk factors in patients with retinal angiomatous pro...
PurposeThe present study aimed to evaluate the characteristics of fundus autofluorescence in Japanes...
Retinal angiomatous proliferation (RAP) is a distinct form of choroidal neovascularization which may...
Item does not contain fulltextPURPOSE: To identify genetic and environmental risk factors in patient...
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for...
Purpose: To identify signs occurring more frequently in retinal angiomatous proliferation (RAP) lesi...
Retinal angiomatous proliferations (RAP) are one rare exudative maculopathy, occurring only in 10% o...
BACKGROUND: The aim of this study was to identify the clinical and angiographic features of retinal ...
Objectives: To present the multimodal imaging characteristics of precursor retinal angiomatous proli...
Objectives: To present the multimodal imaging characteristics of precursor retinal angiomatous proli...
Purpose: To describe the photoreceptor–retinal pigment epithelium (RPE) interface changes and to ana...
Abstract PURPOSE: To study the advent of exudative age-related macular degeneration in uninvolved fe...
Abstract PURPOSE: To study the advent of exudative age-related macular degeneration in uninvolved fe...
WOS: 000432603700004PubMed ID: 29755818Objectives: To present the multimodal imaging characteristics...
Objective: To report the management of retinal angiomatous proliferation (RAP), a recently described...
PURPOSE: To identify genetic and environmental risk factors in patients with retinal angiomatous pro...
PurposeThe present study aimed to evaluate the characteristics of fundus autofluorescence in Japanes...
Retinal angiomatous proliferation (RAP) is a distinct form of choroidal neovascularization which may...
Item does not contain fulltextPURPOSE: To identify genetic and environmental risk factors in patient...
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for...